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This is a brief summary of the 4th International Meeting of the African-Caribbean Cancer Consortium (AC3),
organized and sponsored by Fox Chase Cancer Center (FCCC), and held on July 21–22, 2012 at the Lincoln University
Graduate Center, Lincoln Plaza, Philadelphia, Pennsylvania. AC3 investigators gathered in Philadelphia, PA to
present the results of our ongoing collaborative research efforts throughout the African Diaspora. The general
theme addressed cancer health disparities and presentations represented all cancer types. However, there was
particular emphasis on women’s cancers, related to human papillomavirus (HPV) and human immunodeficiency
virus (HIV) infections.
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The Fourth International Conference of the African-
Caribbean Cancer Consortium (AC3) was held on July
21st and 22nd, 2012 at the Lincoln University Graduate
Center, Lincoln Plaza at 3020 Market Street, Philadelphia
PA, 19104. Conference presentations had a scientific em-
phasis on women’s cancers with an overarching theme,
“Continuing to Build Capacity to Address Cancer Health
Disparities in Populations of African Descent,” which
highlighted the call for high-quality, innovative global can-
cer research collaborations.
Disparities in access to health care along with environ-
ment and host/genetic factors are thought to contribute
to the increased cancer risk in minority populations.
Among the numerous studies that have investigated
gene-environment interactions and cancer risk, most
do not include participants of African ancestry; others* Correspondence: Camille.ragin@fccc.edu
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unless otherwise stated.include small numbers, which results in the inability to
report meaningful, generalizable results for this popula-
tion. This was confirmed by several meta and pooled
analyses of the published literature on genetic suscepti-
bility factors and cancer [1-3].
In addition to gene-environment interactions, socio-
economic factors, access to care, lifestyle and other host
factors are significant contributors to cancer incidence
and mortality. Many studies have sought to address
these factors in the African Diaspora, but few studies
consider all of these factors in combination.
The current racial disparity in cancer incidence and
mortality that exists in the United States has been well
described in the literature; the rising burden of cancer is
also evident in developing countries [4]. The International
Agency for Research on Cancer (IARC) predicted a 40%
increase in the number of cancer deaths between 2012
and 2035 in developed countries; for developing countries,
more than a 90% increase is expected [5]. Cancer is among
the top five leading causes of death in the Caribbean
Islands [5]. With a particular focus on women’s cancers,
the burden of cervical cancer is highest in Sub-Saharanral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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oped regions of the world, age-adjusted mortality rates are
considerably high in both Eastern and Western Africa,
where mortality rates were approximately 35 and 25 per
100,000, respectively [6,8]. Socioeconomic status, advanced
disease at diagnosis, and access to effective screening
programs are well established risk factors in the increased
cancer incidence and mortality among Caribbean and
African populations; however, the role in which genetics
and environmental exposures play in carcinogenesis within
this diverse population is relatively unknown. Therefore, by
studying the patterns of cancer incidence and mortality in
Caribbean and African populations, we may gain insight on
gene-environment interactions related to cancer etiology in
these groups.
This meeting focused our attention on the significant
need for studies related to cancer in women of African
descent, including special considerations for cultural dif-
ferences and environmental exposures among African-
American, African-Caribbean and African populations as
a whole. Table 1 summarizes the meeting schedule for
both days of the conference. Various topics revolving
around cancer research were discussed in hopes to
stimulate the sharing of new ideas and the creation of
new collaborations. The uniqueness of this conference
design was to promote the integration of participants,
researchers, students and community partners so as to
promote effective knowledge-exchange.
A groundbreaking component was added to this con-
ference; embedded within the scientific program was a
special symposium for community participants. The in-
volvement of community members allowed researchers
to better understand the barriers related to minority par-
ticipation in biomedical research and clinical trials. Fur-
thermore, by attending the conference community
members were offered the opportunity to become more
knowledgeable about current research progress and the
overall importance of research in cancer prevention and
treatment. If the community were to become more
aware of the positive impact of research on cancer preven-
tion and cancer outcomes, and if this novel interaction
were to promote trust of the investigators conducting the
research within their community, then persons would be
better equipped to recognize the value of participating in
biomedical research and/or clinical trials. This was the
basis for the integration of community participation into a
scientific conference.
To ensure a broad representation of the various African
ethnic populations throughout Philadelphia County,
individual community leaders and well-established
community-based organizations worked in partnership
with the AC3 leadership to plan, organize and host the ses-
sions during the community symposium. The organizations
included the African Family Health Organization (AFAHO),Caribbean Festival & Cultural Organization of Pennsylvania
(“Philadelphia Caribbean Festival Committee”), The Elise
Joseph Foundation, The Coalition of African Communities
(AFRICOM), National Black Leadership Initiative in
Cancer - Philadelphia Chapter, and Sharing Health and
Hope in Cameroon Africa (SHAHICA).
The community symposium involved free health screen-
ings and workshops that provided scientific investigators
the opportunity to present their research findings to the
communities. The workshops were interactive and pro-
vided an opportunity for bi-directional knowledge transfer
between the community and researchers. These work-
shops facilitated the setting of research priorities for ad-
dressing cancer health disparities. Another vital aspect at
the forefront of the 2012 conference was the highlighted
importance of cancer registries, especially in the develop-
ing countries.
Saturday July 1st 2012
The opening ceremony was launched by Dr. Robert R.
Jennings, (President, Lincoln University, USA) who wel-
comed all researchers and community leaders to the
conference. Dr. Camille Ragin, lead investigator of the
AC3, provided a summary of the preceding conferences
and the goals moving forward. The Keynote Address
was presented by Representative Ronald G. Waters, State
Representative for the 191st Legislative District (Delaware
and Philadelphia counties, USA). Rep. Waters, who dedi-
cated much of his career to correcting health disparities,
spoke on cultural competency and addressed women’s
health disparities and the best practice models in research
and outreach.
Scientific presentations
Session I: Women’s cancers
The first scientific session was chaired by Dr. Norma
McFarlane-Anderson, Professor of Basic Medical Sci-
ences, University of the West Indies, Kingston, Jamaica.
Dr. Okey Ibeanu, Gynecologic Oncologist and Assistant
Professor at Johns Hopkins University, was the Plenary
Speaker for this session. His main research interest is in
cervical dysplasia and cancer, as well as outcomes re-
search in minority populations receiving cancer care in
the U.S. and abroad. Dr. Ibeanu is actively involved in
global health activities in Africa. In Dr. Ibeanu’s address
he discussed global and regional epidemiology of cer-
vical cancer. He also described individual and system-
related factors that impacted cervical cancer patients in
Africa and provided suggestions for improvement. The
session concluded with two additional short presenta-
tions of selected abstracts by students. The presentations
were entitled “Racial/Ethnic Differences in Vitamin D
Supplementation among Breast Cancer Survivors” and
“Cancer and You: Perspectives from African Women.”
Table 1 Meeting schedule at a glance
SATURDAY, JULY 21, 2012
Opening Scientific & Training Conference
“Continuing to Build Capacity to Address Cancer Health
Disparities in Populations of African Descent”
8:00 – 8:30 Continental Breakfast
8:30 – 9:00 Opening Statements, Welcome
Keynote Address Targeting Women’s Health Disparities: Best-
practice Models in Research and Outreach
9:00 – 9:45
Scientific Session I Women’s Cancers in Minority Populations
9:45 – 10:45
Scientific Session II HPV Associated Cancers
11:00 – 11:45
Cancer Prevention and Research Information
“An ounce of prevention is worth more than a pound of cure!”
(Community Sessions)
Lunch N Learn* Black Women and Cancer: Epidemiology,




Healthy Lifestyles: Reducing Cancer Risk
1:15 – 1:45
Panel Discussion I* HPV Vaccination Against Cervical Cancer
1:45 – 2:30



















What you Always Wanted to Know About
Cancer Research and Clinical Trials
5:00 – 6:15
Cancer Session I* I Have Cancer, Now What?
6:15 – 7:15
SUNDAY, JULY 22, 2012
Scientific Training Program (Continued)
7:30 – 8:30 Continental Breakfast
Keynote Address Cancer Genetics, Genomics and
Personalized Medicine
8:30 – 9:20
Scientific Session III Holistic Medicine and Cancer Therapeutics
9:20 – 10:15
Scientific Session IV Cancer in Developing Countries
10:30 – 11:15
Table 1 Meeting schedule at a glance (Continued)
Collaborative Workshop I Lunch N Learn & Panel Discussion II: How to
Establish Successful Collaborations
11:15 – 12:15




Best Practices in Research
1:15 – 2:15





Grant Writing: Features of a Successful Grant
Application; the Grant Review Process; Mock
Study-section Review
3:30 – 5:00
Scientific Session VII Project Development Workshop
5:15 – 6:15
Closing Remarks and Conference Wrap-Up
*Denotes interactive sessions between Community, Scientists & Students.
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This session was chaired by Dr. Darron Halliday, Clinical
Fellow at the Tom Baker Cancer Center in Calgary,
Canada. Dr. Halliday completed his medical training at
the University of the West Indies, Mona Kingston,
Jamaica. His career goal is to advance women’s cancer
care in the Caribbean through collaboration and re-
search with international, government and academic
institutions. Dr. Halliday launched the session with a
presentation on knowledge and attitudes towards HPV
and the HPV vaccines in the Bahamas. His presentation
emphasized the need to strengthen preventative pro-
grams for HPV infection. He suggested that focused
educational programs should be guided by knowledge
and attitude-based studies and that reassurance with re-
spect to HPV vaccine safety and efficacy should also be
addressed. The session concluded after three short pre-
sentations of abstracts: “Knowledge of Cervical Cancer
and HPV and Attitudes towards the Use of Vaccines among
University Students;” “The Detection of All High Risk
Human Papillomavirus DNA in Archival Formalin-Fixed
Paraffin-Embedded Cervical Tissue Using Immunohisto-
chemistry and Polymerase Chain Reaction;” and “Com-
paring Completion and Factors Influencing PAP-testing
among African- and Latina-Americans in Two Regions
with High Cervical Cancer Incidence.”
Research skills workshop I
The Scientific Session for Day 1 concluded with Re-
search Skills Training Workshop I, “Research Methods:
Meta and Pooled Analysis,” by AC3 Principal Investigator
(PI), Dr. Camille Ragin. The training session provided
step-wise instruction on how to conduct a meta-analysis
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the advantages and disadvantages of each type of analysis
and summarized the software used to generate data.
Community symposium
Two types of workshops were offered during the second
half of the day; cancer prevention, and cancer research
information. Community participants were informed of
various research methods, the appropriate time to
screen, how HIV is related to cancer, and clinical trials.
The Community Symposium began at noon with the
Lunch N Learn keynote presentation by Dr. Raleigh
Butler, Director of Gynecologic Oncology, Princess
Margaret Hospital, Nassau, Bahamas. Dr. Butler’s presenta-
tion, “Black Women and Cancer: Epidemiology, Research
and Progress Made,” highlighted healthcare disparities
related to common gynecologic cancers and shared
facts about endometrial, ovarian, lung and breast malig-
nancies. His presentation highlighted the progress made
by the AC3 and other national, regional and global
entities and also discussed future directions for AC3.
Cancer prevention workshop I
The first community workshop, entitled “Healthy Lifestyles:
Reducing Cancer Risk,” was hosted by The Coalition of
African Communities-Philadelphia. The featured speaker,
Carlene Bowen, Registered Transplant Dietician at Thomas
Jefferson University Hospital, Philadelphia, PA, helped
the audience identify modifiable and non-modifiable
risk factors associated with cancer development. Ms.
Bowen discussed the link between diet, physical activity
and health-promoting behaviors, with certain types of
cancers.
Cancer prevention workshop II
The second community workshop, entitled “When do
I Screen?” was hosted by the African Family Health
Organization (AFAHO). Dr. Deborah K. Witt, Assistant
Professor in the Department of Family and Community
Medicine at Thomas Jefferson University Hospital,
Philadelphia, PA, presented on the importance of screen-
ing for the African American community. Dr. Witt’s
presentation defined proper screening habits and
reviewed established recommendations for screening
for colon, cervical, prostate and breast cancer.
Cancer prevention workshop III
Sharing Health and Hope in Cameroon Africa (SHA-
HICA) hosted the final cancer prevention workshop of
the community symposium. Dr. Ngozi Onuoha, a geriat-
ric internist within the University of Pennsylvania Health
System, Philadelphia, PA, presented on behalf of Dr.
Helen Kwa kwa, Director of HIV Clinical Services at the
Philadelphia Department of Health. The goal of thepresentation, entitled “How is HIV Related to Cancer?”
was to highlight the risk of cancer within the HIV-
infected population. Some questions that were addressed
throughout the presentation were: 1) Why do people liv-
ing with HIV have a higher risk of cancer? 2) Has the
introduction of antiretroviral treatment changed the risk
of developing cancer for people infected with HIV? and
3) What can people living with HIV do to reduce their
risk of cancer or to detect cancer early?Cancer research information session I
The Philadelphia Caribbean Festival Committee hosted
the symposium’s cancer research session. The session
included two presentations: “Principles of Cancer Re-
search,” presented by AC3 PI Camille Ragin, and “What
You Always Wanted to Know about Cancer Research
and Clinical Trials, But Did Not Know Who to Ask!”
presented by Ernestine P. Delmoor, MPH, President
of the National Black Leadership Initiative in Cancer-
Philadelphia Chapter, PA. Dr. Ragin’s presentation gave
an overview on the different types of study designs used
in cancer research, emphasizing the impact of cancer re-
search on improving health and the importance of mi-
nority participants in research studies. Ms. Delmoor
began an open discussion that focused around medical
research in the minority community and whether or not
there are collective health benefits for minorities to par-
ticipate in clinical trials. Ms. Delmoor’s presentation
aimed to help community members become more com-
fortable talking about cancer research and clinical trials.
The presentation enabled the audience to make the con-
nection between health care, clinical trials and racial
disparities.Satellite meeting I
While this AC3 conference focused on women’s cancers,
the meeting organizers noted the significant impact that
prostate cancer has on women and their families. There-
fore, a special session was organized to address this im-
portant men’s health topic. A Town Hall meeting for
men was held as a satellite session concurrently sched-
uled with Cancer Prevention Workshop III and Cancer
Research Information Session I. The meeting was de-
signed for male participants only to discuss prostate can-
cer, screening and dispel myths. The Town Hall meeting
was facilitated by prostate cancer survivor and radio
personality of Philadelphia’s 105.3 WDAS, Mr. Doug
Henderson. The panelists included behavioral scientist
Dr. JoAnn Oliver (USA), urologists Drs. Robin Roberts
(Bahamas) and Robert Yearwood (Grenada), community
advocate and prostate cancer survivor Robert Nelson
(USA), as well as radiation oncologist, Dr. Curtland
Deville (USA).
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Dr. Carolyn Fang, Co-Leader, Cancer Prevention and
Control, Fox Chase Cancer Center, USA, and Dr. Camille
Ragin, launched Day 2 of the conference with opening re-
marks. Dr. Jose Russo, Director, Breast Cancer Research
Laboratory and the NCI-NIEHS Breast Cancer and the
Environment Research Center, Fox Chase Cancer Center,
followed with the Keynote Address. Dr. Russo’s presenta-
tion addressed a genomic personalized approach to breast
cancer prevention. This was followed by a featured ab-
stract presentation by Dr. Renee Reams, Florida A&M
University. Dr. Reams’s talk provided an example of identi-
fying key pathways important in aggressive cancer using a
genomics approach.
Scientific session III: holistic medicine and cancer therapeutics
The first general scientific session, “Holistic Medicine and
Cancer Therapeutics,“ was chaired by Dr. Maria Jackson,
Senior Lecturer in the Department of Community Health
and Psychiatry at the University of the West Indies, Mona
in Kingston, Jamaica. The session consisted of two presen-
tations by Drs. Lawrence Williams from the University of
the West Indies, Mona, Jamaica, and Esther Matu from
the Kenya Medical Research Institute. Dr. Williams
presented information on Dibenzyl trisulfide (DTS), a
cytotoxic agent isolated from Petivera alliacea and its
effects on neuroblastoma, breast and ovarian cancers.
DTS is derived from the Guinea hen weed, has also
been used for enhancing the immune system, treating dia-
betes, improving memory, and as an anti-inflammatory.
Dr. Williams explained that DTS exhibits potent anti-
proliferation/cytotoxic activity on a wide range of cancer
cell lines specifically through a cytokine switching mech-
anism that down-regulates cytokines in the T1 helper cells
(cytokines that have pro-inflammatory properties) and
up-regulates those in the T2 helper cells. Dr. Matu
presented information on African traditional medicine
(ATM) in the management of cancers. Dr. Matu’s presen-
tation began with a detailed description of ATM and how it
should be considered an indigenous system of healthcare
and not complimentary and/or alternative health care. Dr.
Matu provided the audience with several examples of plants
and herbs that are currently being used in traditional medi-
cine practices in Kenya, which included Prunus Africana,
used in the treatment of benign prostate hyperplasia; and
Vernonia spp, used in the treatment of oesophageal cancer.
Dr. Matu stressed that most remedies used in ATM have
not reached the clinical evaluation stage, but that it was
important to note that yesterday’s folk remedies may one
day be what the 21st century doctor orders.
Scientific session IV: cancer in developing countries
The second general scientific session for Day 2 focused
on cancer in developing countries and was moderatedby Dr. Samuel Gathere, Consultant Otolaryngologist and
Research Officer at the Kenya Medical Research Insti-
tute. Dr Gathere started the session by describing cancer
statistics from the National Cancer Registry in Kenya
where breast and cervical cancers were most prominent
among women. The session continued with presenta-
tions from three Caribbean Cancer Registries as well as
a presentation by Dr. Belinda Morrison, who highlighted
the impact of the National Health Fund policy on cancer
treatment in Jamaica. Although Dr. Morrison’s presenta-
tion focused on prostate cancer rather than women’s
cancer, it provided a good example of the impact of
health policy decisions in developing countries on facili-
tating greater access to newer types of treatment, thus
ultimately improving health outcomes.
Afternoon sessions
The second half of Day 2 focused on sessions geared to-
ward research capacity building that will help to sustain
global cancer research. A panel discussion was facilitated
by Dr. Robin Roberts on “How to Establish Successful
Collaborations.” The panelists included community leaders
Dr. Vera Tolbert from Philadelphia and Dr. Delroy Louden
from the Caribbean, as well as researchers Dr. Renee Reams
from the U.S. and Dr. Dionne Dames from the Caribbean.
A session on “Building Successful Consortia” provided
presentations from leaders of three global consortia −Dr.
Folakemi Odedina, University of Florida, representing the
Prostate Cancer Transatlantic Consortium (CaPTC), Dr.
Timothy Rebbeck, University of Pennsylvania, representing
the Men of African Descent and Carcinoma of the Prostate
(MADCaP), and Dr. Camille Ragin, Fox Chase Cancer Cen-
ter, representing the African-Caribbean Cancer Consortium
(AC3).
Research skills workshop II
This workshop was facilitated by Theresa Berger, MBE,
Director of Academic Affairs, Fox Chase Cancer Center,
Philadelphia, PA provided instructions on best practices
in research. The presentations highlighted hypothesis
development, research study design, planning and man-
agement of a research study, ethics and responsible
conduct of research. Additional areas covered in this
workshop were health literacy and communications, plan-
ning and organizational skills in community outreach, cul-
tural competency and community-based interventions.
Research Skills Workshop III was presented by Dr.
Folakemi Odedina, University of Florida, who provided
instruction on grant writing and features of a successful
grant application. Scientific Session VI provided informa-
tion on funding opportunities: local, national and inter-
national. The presentations were made by Dr. Nina
Ahmad from the Philadelphia Foundation and Dr. Damali
Martin from the National Cancer Institute, Epidemiology





Training Workshops Scientific Workshops
Figure 1 Box plots showing participant mean scores of each scientific (blue) and training (pink) session according to relevance,
presentations and knowledge gained (ranked 1 low - 5 high). Error bars refer to the range of mean scores, and the vertical line within each
box plot refers to the mean of the mean scores.
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Flanigan from the National Cancer Institute, Center for
Global Health. Session VII, the Project Development
Workshop, was chaired by Ms. Theresa Berger, Fox Chase
Cancer Center, during which pilot projects were presented
by junior investigators in order to gain feedback from se-
nior research investigators.
Satellite meeting 2
A meeting hosted by the National Cancer Institute,
Center for Global Health was held concurrently with
the Project Development Workshop and involved all
of the cancer registrars that attended the conference.





Figure 2 Box plots showing participant mean scores for each commu
knowledge gained (ranked 1 low - 5 high). Error bars refer to the range
to the mean of the mean scores.Institute, Center for Global Health’s vision for building
capacity for cancer registration in the Caribbean.
Countries represented included Anguilla, Grenada,
Guyana, Jamaica and Martinique. The need to estab-
lish a regional cancer registry in the Caribbean was
agreed upon by all in attendance, and a future meeting
that would include stakeholders, cancer registrars
and representatives of the Ministries of Health was
recommended.
Throughout the conference, participants (community,
researchers and students) discussed the status of the on-
going collaborative studies and defined research prior-
ities for future studies. The conference concluded with
closing remarks by Dr. Camille Ragin.3 4 5
Mean score
munity Workshops
nity session according to relevance, presentations and
of mean scores, and the vertical line within each box plot refers
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Evaluation forms were distributed for both conference
days. For each session, the relevance of the topic, quality
and speaker presentations, and knowledge gained were
evaluated. Attendees had the opportunity to answer
questions rating 1–5 (1 = lowest rating and 5 = highest
rating) Participants were also asked to provide their
comments and feedback in short answers. Attitudes to-
ward venue and session length were also rated 1–5.
All sessions were grouped into broad categories (Scien-
tific, Training or Community). Mean scores (participant
score ÷ total number of participants) were calculated for
each session. An overall mean score for each broad cat-
egory was determined by calculating the mean of means for
each session within each category (session score ÷ total
number of sessions). Figure 1 summarizes the mean evalu-
ation scores for the scientific and training workshops based
on relevance, presentations and knowledge gained. In the
scientific workshop, the number of participants that com-
pleted the evaluation surveys in each session varied from
36 to 43 persons. In the training workshop, the number of
completed evaluation surveys obtained varied from one to
34 in each session. On average, participants felt that the
topics presented during the sessions were quite relevant
and the presentations were above average. Based on their
knowledge prior to attending each session, participants in-
dicated that they learned a lot.
Figure 2 summarizes the mean evaluation scores for
the community workshops based on relevance, presenta-
tions and knowledge gained. The number of completed
evaluation surveys obtained varied from 6 to 28 in each
session. Similar to the scientific workshops, community
participants felt that the topics presented were quite
relevant and the presentations were above average.
Based on their knowledge prior to attending each ses-
sion, participants indicated that they learned a lot.
There were approximately 20 male participants at the
Town Hall meeting. The men felt that the session was
very effective (overall mean rating = 4.6, mean rating
relevance = 4.7, mean rating presentations/discussion =
4.5 and mean rating knowledge gained = 4.7). The partic-
ipants were asked to comment on the most beneficial as-
pects of the Town Hall meeting. Comments indicated
that discussion surrounding prostate cancer statistics
and the realization that research has succeeded in con-
vincing Black men to screen for prostate cancer were
most beneficial.
Based on the participants’ comments overall, enthusi-
asm was overwhelming. There were references to the su-
perior quality of the keynote speakers and presentations.
Participants were also asked to comment on ways the con-
ference could be improved. There was an overwhelming
request for more time given for question and answers at
the end of each session. Educational brochures could havebeen more helpful for some sessions, and one participant
indicated that there were too many sessions in a single
day. One participant indicated that a future workshop on
“how to build a cancer registry” would have been very
informative.
There were a number of take home messages from the
various sessions. 1) For additional impact there appeared
to be an urgent need for closer collaboration between
the existing cancer registries in the Caribbean region, 2)
there is a need for continued community outreach and
cancer education in the African Diaspora, 3) the type of
challenges related to sustaining cancer screening pro-
grams involving HPV testing and/or Pap testing vary
across different low-resource countries, and 4) cultural
differences impact cancer risk in the African Diaspora.
To our knowledge, this conference was the first of its
kind to integrate community-oriented sessions focused
on the African and Caribbean Diaspora within a trad-
itional scientific conference. The community aspect of
the conference was a success. Community members
were able to gain valuable information on the import-
ance of their roles in cancer prevention and cancer treat-
ment research. The community sessions also allowed
community members to convey, to the scientists, their
fears, concerns, and other hindrances that limit their
willingness to participate in research.
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